Home Stock

Stock Research: ChemoMetec

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

ChemoMetec

CPH:CHEMM DK0060055861
92
  • Value
    19
  • Growth
    63
  • Safety
    Safety
    96
  • Combined
    61
  • Sentiment
    95
  • 360° View
    360° View
    92
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Chemometec A/S develops, manufactures, and sells analytical instruments for quantitative analysis of cells in liquids. It operates in the pharmaceutical, food processing, and agriculture industries with business areas including Instruments, Consumables, and Other (research projects). The company is based in Denmark and has a subsidiary in the USA. In the last fiscal year, the company had 173 employees, a market cap of $1,419 million, profits of $46 million, and revenue of $59 million.

more

ANALYSIS: With an Obermatt 360° View of 92 (better than 92% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock ChemoMetec are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for ChemoMetec. The consolidated Growth Rank has a good rank of 63, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 63% of competitors in the same industry. The consolidated Safety Rank at 96 means that the company has a financing structure that is safer than 96% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 95, which means that professional investors are more optimistic about the stock than for 95% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 19, meaning that the share price of ChemoMetec is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 81% of alternative stocks in the same industry. ...read more

more
Strongest Rank Price vs. Sales (P/S)
Weakest Rank Analyst Opinions
Country Denmark
Industry Life Sciences Tools & Services
Size Small
Website chemometec.com
Index
ChemoMetec stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 26-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
19 10 10 1
Growth
63 100 24 94
Safety
Safety
96 83 96 94
Sentiment
95 88 84 27
360° View
360° View
92 98 61 74
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
100 83 79 n/a
Opinions Change
50 50 50 50
Pro Holdings
n/a 77 88 31
Market Pulse
58 75 33 7
Sentiment
95 88 84 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
19 10 10 1
Growth
63 100 24 94
Safety Safety
96 83 96 94
Combined
61 95 30 80
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
5 1 1 1
Price vs. Earnings (P/E)
30 10 10 10
Price vs. Book (P/B)
7 1 1 1
Dividend Yield
75 49 64 1
Value
19 10 10 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
77 92 1 94
Profit Growth
36 78 72 82
Capital Growth
96 91 64 76
Stock Returns
5 80 8 62
Growth
63 100 24 94
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
100 93 93 97
Refinancing
32 13 30 26
Liquidity
98 100 98 96
Safety Safety
96 83 96 94

Similar Stocks

Discover high‑ranked alternatives to ChemoMetec and broaden your portfolio horizons.

Polski Koncern Naftowy ORLEN Spolka Akcyjna

WSE:PKN
Country: Poland
Industry: Oil & Gas Refining
Size: XX-Large
Full Stock Analysis

Volkswagen VW

GER:VOW
Country: Germany
Industry: Automobile Manufacturers
Size: XX-Large
Full Stock Analysis

Strabag

VIE:STR
Country: Austria
Industry: Construction & Engineering
Size: X-Large
Full Stock Analysis

Alcon

VTX:ALC
Country: Switzerland
Industry: Health Care Supplies
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews